Stockreport

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia [Yahoo! Finance]

Vivani Medical, Inc.  (VANI) 
PDF Study represents the first clinical application of NanoPortalâ„¢, the Company's proprietary drug implant platform technology ALAMEDA, Calif., December 19, 2024 BUSINESS [Read more]